Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Ulcerative Colitis in Adults
2023 Standout
Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study
2022 Standout
Works of P. Rogers being referenced
The safety profile of anti‐tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient‐years follow‐up
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| P. Rogers | 66 | 52 | 109 | 87 | 82 | 21 | 336 | |
| B.K. Amo-Takyi | 54 | 98 | 131 | 43 | 47 | 20 | 397 | |
| Maria Rosaria Limiti | 102 | 67 | 56 | 47 | 49 | 15 | 360 | |
| LiVolsi Va | 39 | 95 | 89 | 66 | 29 | 19 | 406 | |
| Stanley R. McCormick | 36 | 37 | 83 | 119 | 23 | 14 | 401 | |
| Garron J. Solomon | 38 | 76 | 124 | 55 | 32 | 15 | 360 | |
| Marcia A. Ciccone | 44 | 84 | 88 | 52 | 30 | 34 | 408 | |
| Pascale Blouin | 51 | 37 | 114 | 64 | 47 | 22 | 378 | |
| Swati Sood | 30 | 122 | 74 | 80 | 53 | 22 | 323 | |
| Sally L. George | 60 | 18 | 100 | 61 | 39 | 23 | 306 | |
| M F Segers | 83 | 43 | 98 | 21 | 37 | 24 | 383 |
All Works
Login with ORCID to disown or claim papers
Loading papers...